Tilray Brands is advancing its global growth by acquiring the UK-based Lyphe Group, expanding its medical cannabis platform, and strengthening its beverage portfolio, including BrewDog. The company is stabilizing BrewDog's operations and plans to launch Hi*Ball Energy in the UK to capture growth in functional beverages. Tilray is also preparing for potential U.S. medical cannabis rescheduling and has filed an ATM equity program to raise up to $180 million to fund its expansion. These moves position Tilray as a diversified global leader in cannabis, healthcare, and beverages with multiple growth drivers.
The cannabis industry is expanding rapidly with cannabis now classified as a Class 3 substance, reducing legal barriers for operators. This shift allows for more research, product development, and growth opportunities for both cannabis producers and ...
Tilray Brands, a global leader in cannabis and consumer packaged goods, will announce its financial results for the fourth quarter and full fiscal year ending May 31, 2026, on July 28, 2026, after market close. The company will hold a live conference...
BrewDog Waterloo, England's largest pub owned by Tilray Brands, is set to host a major watch party for the England vs Argentina semifinal. The event promises an electric atmosphere with giant screens and passionate fans. Tilray's £1 million bar tab p...
